Trial Profile
Clinical Trials Insight: 700028050
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2007
Price :
$35
*
At a glance
- Drugs Avosentan (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 01 Nov 2007 New trial record.